Author information from the last article
Nevrologisk avdeling
Oslo universitetssykehus
og
Universitetet i Oslo
Forfatterbidrag: utforming, utarbeiding, revisjon og godkjenning av innsendte manusversjon.
Gro Owren Nygaard er overlege og seniorforsker.
Articles by Gro Owren Nygaard
Vaccination of immunosuppressed patients
- Marton König,
- Trygve Holmøy,
- Gro Owren Nygaard,
- Jon Riise,
- Karsten Midtvedt,
- Guro Løvik Goll,
- Kristin Kaasen Jørgensen,
- Ludvig A. Munthe,
- Børre Fevang,
- Anders Eivind Myhre,
- Marius Trøseid
13.04.2026:
Chronically ill patients with a weak immune system are at increased risk of severe infections, often as a result of immunomodulatory therapy rather than the underlying disease. Many patients in this group exhibit reduced vaccine responses and require tailored vaccination regimens. Following the...
Revised diagnostic criteria for multiple sclerosis
- Einar August Høgestøl,
- Piotr Sowa,
- Trygve Holmøy,
- Lars Bø,
- Gro Owren Nygaard,
- Stig Wergeland
08.12.2025:
Biomarkers are given greater emphasis in the revised diagnostic criteria for multiple sclerosis. The diagnosis of multiple sclerosis (MS) is based on clinical symptoms and findings, characteristic MRI changes of the central nervous system and cerebrospinal fluid findings. The revised McDonald...
Norwegian health service should offer stem cell therapy for multiple sclerosis
- Gro Owren Nygaard,
- Trygve Holmøy
12.02.2024:
Many Norwegian patients with multiple sclerosis choose to travel abroad for stem cell therapy at their own expense and risk. Based on the current knowledge base, selected patients should now be offered this therapy in Norway. High-dose chemotherapy with autologous stem cell support (HDT) is not part...
Disease-modifying therapy for multiple sclerosis
- Trygve Holmøy,
- Gro Owren Nygaard,
- Kjell-Morten Myhr,
- Lars Bø
10.05.2021:
High-efficacy therapy from the time of diagnosis substantially improves the prognosis for multiple sclerosis. The national guidelines on MS nevertheless recommend less effective therapy for many patients, and must be updated in pace with medical advances. We consider in the following how multiple...